Aadi Bioscience, Inc.
NASDAQ:AADI
3.21 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 24.354 | 15.216 | 1 | 14 | 0.749 | 20.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.809 | 1.335 | 0.276 | 0.176 | 0.077 | 0 | 0.051 | 0.07 | 0.058 | 0.024 | 0.023 | 0.022 | 0.024 | 0.021 | 0 | 0 |
| Gross Profit
| 21.545 | 13.881 | 0.724 | 13.824 | 0.672 | 20.157 | -0.051 | -0.07 | -0.058 | -0.024 | -0.023 | -0.022 | -0.024 | -0.021 | 0 | 0 |
| Gross Profit Ratio
| 0.885 | 0.912 | 0.724 | 0.987 | 0.898 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 48.929 | 32.662 | 19.67 | 15.008 | 12.824 | 17.853 | 12.147 | 11.368 | 11.625 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 18.511 | 2.121 | 1.854 | 13.486 | 9.241 | 0.029 | 0.023 | 0.023 | 0.022 | 0.024 | 0.021 | 0.021 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 7.825 | -0.047 | -0.051 | 5.167 | 5.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 44.549 | 40.176 | 18.511 | 2.121 | 9.68 | 13.439 | 9.19 | 5.196 | 5.803 | 0.023 | 0.022 | 0.024 | 0.021 | 0.021 | 0 | 0 |
| Other Expenses
| 0 | 5.059 | -0.12 | -0.58 | -0.143 | -0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.034 |
| Operating Expenses
| 93.478 | 72.838 | 38.061 | 16.549 | 22.504 | 31.292 | 21.337 | 16.564 | 17.429 | 0.023 | 0.022 | 0.024 | 0.021 | 0.021 | 0 | -0.034 |
| Operating Income
| -71.933 | -58.957 | -111.217 | -2.549 | -22.581 | -11.181 | -21.389 | -16.634 | -17.487 | -0.023 | -0.022 | -0.024 | -0.021 | -0.041 | 0 | -0.034 |
| Operating Income Ratio
| -2.954 | -3.875 | -111.217 | -0.182 | -30.148 | -0.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.168 | 2.168 | 1.129 | -0.927 | 1.174 | 0.785 | -0.012 | -0.35 | 0.416 | 0.017 | 0.017 | 0.017 | 0.02 | 0.019 | 0 | 0 |
| Income Before Tax
| -65.765 | -60.513 | -110.088 | -3.476 | -23.271 | -10.397 | -21.401 | -16.984 | -17.07 | -0.029 | -0.027 | -0.027 | -0.022 | -0.022 | 0 | -0.034 |
| Income Before Tax Ratio
| -2.7 | -3.977 | -110.088 | -0.248 | -31.069 | -0.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -3.503 | 0.002 | 0.002 | 0.001 | 0.778 | -0.012 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -65.765 | -57.01 | -110.09 | -3.478 | -23.271 | -10.397 | -21.401 | -16.984 | -17.07 | -0.029 | -0.027 | -0.027 | -0.022 | -0.022 | 0 | -0.034 |
| Net Income Ratio
| -2.7 | -3.747 | -110.09 | -0.248 | -31.069 | -0.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.44 | -2.53 | -12.34 | -20.52 | -8.6 | -4.6 | -14.81 | -9.42 | -9.47 | -0.016 | -0.015 | -0.015 | -0.012 | -0.005 | 0 | 0 |
| EPS Diluted
| -2.44 | -2.53 | -12.34 | -20.52 | -8.6 | -4.6 | -14.81 | -9.42 | -9.47 | -0.016 | -0.015 | -0.015 | -0.012 | -0.005 | 0 | 0 |
| EBITDA
| -65.365 | -60.124 | -109.147 | -2.485 | -24.444 | -10.35 | -21.244 | -16.432 | -17.012 | -0.023 | -0.022 | -0.024 | -0.021 | -0.041 | 0 | -0.034 |
| EBITDA Ratio
| -2.684 | -3.717 | -35.463 | -0.189 | -30.046 | -0.552 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |